Anzeige
Mehr »
Login
Dienstag, 04.03.2025 Börsentäglich über 12.000 News von 689 internationalen Medien
Mit Vollgas Richtung Expansion - Gelingt nun der Durchbruch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 905265 | ISIN: SE0000135485 | Ticker-Symbol: 27R
München
04.03.25
08:36 Uhr
22,300 Euro
0,000
0,00 %
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
RAYSEARCH LABORATORIES AB Chart 1 Jahr
5-Tage-Chart
RAYSEARCH LABORATORIES AB 5-Tage-Chart
RealtimeGeldBriefZeit
22,60022,80015:26
PR Newswire
198 Leser
Artikel bewerten:
(1)

RaySearch Laboratories: The Chinese carbon ion center Heyou Hospital selects RayStation

Finanznachrichten News

STOCKHOLM, March 4, 2025 /PRNewswire/ -- RaySearch Laboratories AB (publ) is pleased to announce that Heyou Hospital, located in Foshan City, Guangdong Province, China, has placed an order for the treatment planning system RayStation®*. Total order value (including service contract) is RMB 51 million (approximately SEK 77 million), of which RMB 18 million (approximately SEK 26 million) will be recognized in the first quarter of 2025. This is the third largest order ever for RaySearch and the largest since December 2022. Heyou Hospital is RaySearch's first customer with a combined Hitachi carbon ion and proton machine.

Heyou Hospital is a world-class medical institution offering personalized healthcare and high-quality research with special emphasis on areas such as oncology, neurology, orthopedics, and neurosurgery.

In 2021, Heyou Hospital bought a combined Hitachi carbon ion and proton machine. This will now be complemented with RayStation, which will also be used for treatment planning for the hospital's conventional photon treatment machines.

Ion beam therapy is the most advanced form of external radiotherapy, where the tumor is irradiated with protons or carbon ions. Compared to conventional radiotherapy, where the tumor is irradiated with photons, the energy deposition of the ion beams can be controlled more precisely. This reduces the radiation dose to healthy tissues, leading to a reduction of treatment-related side effects.

The market for particle treatments (protons/carbon ions/BNCT) is growing rapidly in China. RaySearch is the market leader in treatment planning for particle treatments, a position that is further strengthened by this new order.

The purchase will give Heyou Hospital access to advanced RayStation technologies such as pencil beam scanning, robust optimization, linear energy transfer optimization, proton arc optimization, graphic processing unit (GPU) accelerated dose calculations, and adaptive replanning support.

Johan Löf, founder and CEO, RaySearch: "I am pleased to announce our collaboration with Heyou Hospital and the significant order for RayStation. I look forward to deepening our relationship and to a fruitful cooperation in advanced radiation therapy."

This information is information that RaySearch Laboratories AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out below, at 10:55 am CET on March 4, 2025.

For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510?530 00
johan.lof@raysearchlabs.com?

Learn more about us on:
LinkedIn
YouTube
X

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/raysearch-laboratories/r/the-chinese-carbon-ion-center-heyou-hospital-selects-raystation,c4105102

The following files are available for download:

https://mb.cision.com/Main/1102/4105102/3299226.pdf

RaySearch Press release March 4, 2025

https://news.cision.com/raysearch-laboratories/i/press-release-heyou-hospital,c3383509

Press-release Heyou Hospital

* Subject to regulatory clearance in some markets.

Cision View original content:https://www.prnewswire.co.uk/news-releases/the-chinese-carbon-ion-center-heyou-hospital-selects-raystation-302391342.html

© 2025 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.